South Korea Faces Ethical Crisis Over Aesthetic Skin Boosters Derived From Human Cadavers

South Korea reviews regulations on human-derived skin boosters as cadaver-based beauty treatments spark ethical concerns and calls for stricter safety testing.

By: AXL Media

Published: Apr 17, 2026, 8:29 AM EDT

Source: Information for this report was sourced from The Straits Times

The Emerging Market for Human Derived Cosmetics

South Korea’s aesthetics industry is witnessing a controversial shift as companies introduce skin boosters composed of extracellular matrix materials harvested from donated human cadavers. These products, which utilize collagen and other biological components from the deeper layers of skin, are being positioned as high-end alternatives to synthetic treatments. Industry projections indicate that up to seven such products could be active in the South Korean market by the end of 2026, marking a significant expansion from their initial debut in 2024. Despite the commercial momentum, the rapid adoption of these human-derived materials has outpaced the existing regulatory frameworks.

A Regulatory Void in Biological Safety Standards

The core of the legal debate centers on the classification of these injectables, which currently exist in a regulatory gray area between medical transplants and pharmaceutical devices. According to Kwon Dong-ju, a lawyer at Yoon and Yang, oversight is presently limited to basic contamination and infection control rather than the comprehensive clinical trials mandated for other medical innovations. This lack of rigorous testing creates a disparity where human tissue products face significantly more relaxed standards than synthetic devices that undergo years of investment and safety validation before reaching the public.

Ethical Dilemmas Surrounding Human Tissue Donations

At a National Assembly forum held on April 16, experts voiced sharp concerns regarding the commercialization of altruistic acts. Many participants argued that body donations made out of personal or religious convictions should not be leveraged for corporate profit in the aesthetics sector. There is a growing fear that using donated tissue for vanity procedures could alienate potential donors, a critical issue in a nation that sees only about 200 body donations annually. While the Ministry of Health and Welfare notes that these materials are currently imported rather than sourced from domestic donors, the ethical optics remain a major hurdle for the industry.